Literature DB >> 23235744

Intestinal stromal cells in mucosal immunity and homeostasis.

B M J Owens1, A Simmons.   

Abstract

A growing body of evidence suggests that non-hematopoietic stromal cells of the intestine have multiple roles in immune responses and inflammation at this mucosal site. Despite this, many still consider gut stromal cells as passive structural entities, with past research focused heavily on their roles in fibrosis, tumor progression, and wound healing, rather than their contributions to immune function. In this review, we discuss our current knowledge of stromal cells in intestinal immunity, highlighting the many immunological axes in which stromal cells have a functional role. We also consider emerging data that broaden the potential scope of their contribution to immunity in the gut and argue that these so-called "non-immune" cells are reclassified in light of their diverse contributions to intestinal innate immunity and the maintenance of mucosal homeostasis.

Entities:  

Mesh:

Year:  2012        PMID: 23235744     DOI: 10.1038/mi.2012.125

Source DB:  PubMed          Journal:  Mucosal Immunol        ISSN: 1933-0219            Impact factor:   7.313


  39 in total

1.  Interleukin-1 (IL-1) signaling in intestinal stromal cells controls KC/ CXCL1 secretion, which correlates with recruitment of IL-22- secreting neutrophils at early stages of Citrobacter rodentium infection.

Authors:  Yong-Soo Lee; Hyungjun Yang; Jin-Young Yang; Yeji Kim; Su-Hyun Lee; Ji Heui Kim; Yong Ju Jang; Bruce A Vallance; Mi-Na Kweon
Journal:  Infect Immun       Date:  2015-08       Impact factor: 3.441

Review 2.  Stromal cell regulation of homeostatic and inflammatory lymphoid organogenesis.

Authors:  Matthew J W Kain; Benjamin M J Owens
Journal:  Immunology       Date:  2013-09       Impact factor: 7.397

Review 3.  The role of sex hormones in immune protection of the female reproductive tract.

Authors:  Charles R Wira; Marta Rodriguez-Garcia; Mickey V Patel
Journal:  Nat Rev Immunol       Date:  2015-03-06       Impact factor: 53.106

4.  Intestinal knockout of Nedd4 enhances growth of Apcmin tumors.

Authors:  C Lu; C Thoeni; A Connor; H Kawabe; S Gallinger; D Rotin
Journal:  Oncogene       Date:  2016-04-18       Impact factor: 9.867

5.  IL-33 activates tumor stroma to promote intestinal polyposis.

Authors:  Rebecca L Maywald; Stephanie K Doerner; Luca Pastorelli; Carlo De Salvo; Susan M Benton; Emily P Dawson; Denise G Lanza; Nathan A Berger; Sanford D Markowitz; Heinz-Josef Lenz; Joseph H Nadeau; Theresa T Pizarro; Jason D Heaney
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-27       Impact factor: 11.205

6.  CD90(+) stromal cells are the major source of IL-6, which supports cancer stem-like cells and inflammation in colorectal cancer.

Authors:  Phuong T Huynh; Ellen J Beswick; Yun A Coronado; Paul Johnson; Malaney R O'Connell; Tammara Watts; Pomila Singh; Suimin Qiu; Katherine Morris; Don W Powell; Irina V Pinchuk
Journal:  Int J Cancer       Date:  2015-12-10       Impact factor: 7.396

7.  Compartmentalized and systemic control of tissue immunity by commensals.

Authors:  Yasmine Belkaid; Shruti Naik
Journal:  Nat Immunol       Date:  2013-07       Impact factor: 25.606

8.  Myofibroblasts are distinguished from activated skin fibroblasts by the expression of AOC3 and other associated markers.

Authors:  Lin-Ting Hsia; Neil Ashley; Djamila Ouaret; Lai Mun Wang; Jennifer Wilding; Walter F Bodmer
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-28       Impact factor: 11.205

9.  Estradiol-regulated innate antiviral responses of human endometrial stromal fibroblasts.

Authors:  Mickey V Patel; Zheng Shen; Richard M Rossoll; Charles R Wira
Journal:  Am J Reprod Immunol       Date:  2018-09-17       Impact factor: 3.886

10.  TLR4 activation enhances the PD-L1-mediated tolerogenic capacity of colonic CD90+ stromal cells.

Authors:  Ellen J Beswick; Jameel R Johnson; Jamal I Saada; Martin Humen; Jenifer House; Sara Dann; Suimin Qiu; Allan R Brasier; Don W Powell; Victor E Reyes; Irina V Pinchuk
Journal:  J Immunol       Date:  2014-07-28       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.